Reduced cardiovascular risk after bariatric surgery is linked to plasma ceramides, apolipoprotein-B100, and ApoB100/A1 ratio.
about
Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosisRoux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission.Role of ceramides in nonalcoholic fatty liver diseaseLonger-Term Physiological and Metabolic Effects of Gastric Bypass SurgeryImpact of gastrointestinal surgery on cardiometabolic risk.Lipidomic profiling at the interface of metabolic surgery and cardiovascular disease.Metabolomics-guided insights on bariatric surgery versus behavioral interventions for weight loss.Association Between Subtotal Gastrectomy with Billroth II Anastomosis and Coronary Heart Disease.Lipidomic profiling before and after Roux-en-Y gastric bypass in obese patients with diabetes.Bariatric Surgery Resistance: Using Preoperative Lifestyle Medicine and/or Pharmacology for Metabolic Responsiveness.Time course metabolome of Roux-en-Y gastric bypass confirms correlation between leptin, body weight and the microbiome.Changes in Serum Sphingomyelin After Roux-en-Y Gastric Bypass Surgery Are Related to Diabetes Status.
P2860
Q28547365-7937FABE-7BC3-454E-98D7-2659074F5399Q35577707-D2DF79D2-F29A-4278-9A40-D6202CA40297Q36129432-AE399A3C-BF00-4DDA-959A-2391893B2D12Q37550281-5FE4BE9F-AAA6-46E2-B7E0-B85CB407D487Q38051207-E97F4BDF-BDED-41F7-BC1F-F5358356A7EBQ38252517-4E4FF6A4-5BE1-4A47-B008-21E398E07F3FQ39021881-601CEDB5-6F9A-4C68-A24A-36B47CBA7555Q39025644-A8126457-3E4B-45A6-A036-1482AAA96ACCQ39288685-76700418-DFAF-4531-9787-FC4B5D4925EEQ45070738-3E7770F9-8D71-49F4-9A24-AA721EE0EAAAQ55156251-1CCDE57E-2D56-43EE-8D92-013294C117E6Q55290172-8D9F445F-8D28-472A-B940-9A5436ED1E09
P2860
Reduced cardiovascular risk after bariatric surgery is linked to plasma ceramides, apolipoprotein-B100, and ApoB100/A1 ratio.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Reduced cardiovascular risk af ...... in-B100, and ApoB100/A1 ratio.
@ast
Reduced cardiovascular risk af ...... in-B100, and ApoB100/A1 ratio.
@en
type
label
Reduced cardiovascular risk af ...... in-B100, and ApoB100/A1 ratio.
@ast
Reduced cardiovascular risk af ...... in-B100, and ApoB100/A1 ratio.
@en
prefLabel
Reduced cardiovascular risk af ...... in-B100, and ApoB100/A1 ratio.
@ast
Reduced cardiovascular risk af ...... in-B100, and ApoB100/A1 ratio.
@en
P2093
P2860
P1476
Reduced cardiovascular risk af ...... in-B100, and ApoB100/A1 ratio.
@en
P2093
Arthur J McCullough
Hazel Huang
Heather L Gornik
Helen M Heneghan
John P Kirwan
Philip R Schauer
Sangeeta R Kashyap
Stacy A Brethauer
Takhar Kasumov
P2860
P304
P356
10.1016/J.SOARD.2011.11.018
P577
2011-12-20T00:00:00Z